News

By Priscila Mayumi Kashiwabara

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.

Access the full guide, published by IAM and written by Priscila Kashiwabara, Marisa Momoli and Livia Figueiredo by clicking here.
Back

Last by Priscila Mayumi Kashiwabara

1 de July de 2026

INPI Ordinance No. 80/2026 and Second Medical Use Patents

INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination INPI Ordinance No. 80/2026 and Second Medical Use Patents

Ler notícia

29 de May de 2026

Kasznar Leonardos has been ranked by IAM Patent 1000

It is with great honor that we announce that we have once again been ranked in the IAM Patent 1000. In the Kasznar Leonardos has been ranked by IAM Patent 1000

Ler notícia

17 de June de 2025

Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation

On June 11th, 2025, the Brazilian Senate approved Legislative Decree No. 466/2022, ratifying Brazil’s accession to the Budapest Treaty on the International Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation

Ler notícia